References

  1. Belkhadir J. Le diabète en milieu marocain en 200 Congrès du Groupe Pan-Africain Pour l'Etude du Diabète. Casablanca, 24 - 26 mai 200. PubMed | Google Scholar

  2. Weintraub WS, Grau-Sepulveda MV, Weiss JM et al. Comparative effectiveness of revascularization strategies. N Engl J Med. 2012;366(16):1467-76. PubMed | Google Scholar

  3. Yusuf S, Hawken S, Ounpuu S et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries. (INTERHEART study): case-control study. Lancet. 2004;364(9438):937-52. PubMed | Google Scholar

  4. Soares PR, Hueb WA, Lemos PA et al. Coronary revascularization (surgical or percutaneous) decreases mortality after the first year in diabetic subjects but not in nondiabetic subjects with multivessel disease: an analysis from the Medicine, Angioplasty, or Surgery Study (MASS II). Circulation. 2006; 114(Suppl):420-4. PubMed | Google Scholar

  5. Brooks MM, Chaitman BR, Nesto RW et al. Clinical and Angiographic Risk Stratification and Differential Impact on Treatment Outcomes in the BARI 2D Trial.Circulation. 2012; 126(17):2115-24. PubMed | Google Scholar

  6. Daemen J, Kuck KH, Macaya C et al. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-Year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) Trial. JACC 2008;52(24):1957-67. PubMed | Google Scholar

  7. Kapur A, Hall RJ, Malik IS et al. Randomized comparison of percutanuous coronary intervention with CABG in diabetic patients : 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) . Trial. JACC 2010;55(5):432-40. PubMed | Google Scholar

  8. Bravata DM, Gienger AL, McDonald KM et al. Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery. Ann Intern Med. 2007;147(10):703-16. PubMed | Google Scholar

  9. Gibbons R, Fihn S. Coronary revascularization: new evidence, new challenges. Ann Intern Med. 2007;147(10):732-4. PubMed | Google Scholar

  10. Antunes PE, De Oliveira JF, Antunes MJ. Coronary surgery in patients with diabetes mellitus: a risk-adjusted study on early outcome. Euro J Cardiothorac Surg. 2008; 34(2):370-6. PubMed | Google Scholar

  11. Lee M, Jamal F, Kedia G. Comparison of bypass surgery with drug-eluting stents for diabetic patients with multivessel disease. Intern J Cardiol. 2007 ;123 : 34-42. PubMed | Google Scholar

  12. Gandjbakhch I, Leprince P, D'Alessandro C et al. La revascularisation chirurgicale des patients coronariens diabétiques. Bull Acad Natl Med. 2005 Feb;189(2):257-66 discussion 266-7. PubMed | Google Scholar

  13. Magaji V, Nayak S, Donihi AC et al. Comparison of insulin infusion protocols targeting 110-140 mg/dl in patients after cardiac surgery. Diabetes Technol Ther. 2012 Nov;14(11):1013-7. PubMed | Google Scholar

  14. Nalysnyk L, Fahrbach K, Reynolds MW et al. Adverse events in coronary artery bypass graft (CABG) trials: a systematic review and analysis. Heart. 2003;89(7):767-7. PubMed | Google Scholar

  15. Cakmak M, Cakmak N, Cetemen S et al. The value of admission glycosylated hemoglobin level in patients with acute myocardial infarction. Can J Cardiol. 2008;24(5):375-8. PubMed | Google Scholar

  16. Ngaage DL, Jamali AA, Griffin S et al. Non-infective morbidity in diabetic patients undergoing coronary and heart valve surgery. Eur J Cardio-Thorac Surg. 2009; 35(2): 255-9. PubMed | Google Scholar

  17. Toumpoulis IK, Theakos N, Dunning J. Does bilateral internal thoracic artery harvest increase the risk of mediastinitis. Interact Cardiovasc Thorac Surg. 2007 Dec;6(6):787-91. PubMed | Google Scholar

  18. Abboud CS, Wey SB, Baltar VT. Risk factor for mediastinitis after cardiac surgery. Ann Thorac Surg. 2004;77(2):676-83. PubMed | Google Scholar

  19. Li JY, Sun S, Wu SJ. Continuous insulin infusion improves postoperative glucose control in patients with diabetes mellitus undergoing coronary artery bypass surgery. Tex Heart Inst J. 2006;33(4):445-51. PubMed | Google Scholar

  20. Schmeltz LR, DeSantis AJ, Thiyagarajan V et al. Reduction of surgical mortality and morbidity in diabetic patients undergoing cardiac surgery with a combined intravenous and subcutaneous insulin glucose management strategy. Diab Care. 2007;30(4):823-8. PubMed | Google Scholar

  21. Ledur P, Almeida L, Pellanda LC, Schaan BD. Predictors of infection in post-coronary artery bypass graft surgery. Rev Bras Cir Cardiovasc. 2011 Apr-Jun;26(2):190-6. PubMed | Google Scholar

  22. Farsky PS, Graner H, Duccini P et al. Risk factors for sternal wound infections and application of the STS score in coronary artery bypass graft surgery. Rev Bras Cir Cardiovasc. 2011 Oct-Dec;26(4):624-9. PubMed | Google Scholar

  23. Abboud CS, Wey SB, Baltar VT. Risk factors for mediastinitis after cardiac surgery. Ann Thorac Surg. 2004 Feb;77(2):676-83. PubMed | Google Scholar

  24. Magedanz EH, Bodanese LC, Guaragna JC et al. Risk score elaboration for mediastinitis after coronary artery bypass grafting. Rev Bras Cir Cardiovasc. 2010 Apr-Jun;25(2):154-9. PubMed | Google Scholar

  25. Blasco-Colmenares E, Perl TM, Guallar E et al. Aspirin plus clopidogrel and risk of infection after coronary artery bypass surgery. Arch Intern Med. 2009 Apr 27;169(8):788-96. PubMed | Google Scholar